Biological process |
GO:0030198~extracellular matrix organization |
2.87E−06 |
CRISPLD2, FBN1, NID1, COL1A1, SPARC, COL5A1, SPP1 |
GO:0032355~response to estradiol |
3.72E−05 |
ALDH1A2, SOCS2, PTCH1, COL1A1, PTEN |
GO:0003007~heart morphogenesis |
3.95E−05 |
FLRT2, ALDH1A2, PTCH1, COL5A1 |
GO:0030199~collagen fibril organization |
7.20E−05 |
TNXB, TNXA, COL1A1, COL5A1 |
GO:0045893~positive regulation of transcription, DNA-templated |
7.81E−05 |
FOXL2, OSR2, GDF7, IGF1, PTCH1, COL1A1, TBL1X, WT1 |
GO:0007507~heart development |
5.49E−04 |
EDNRA, FBN1, SPARC, PTEN, WT1 |
GO:0000122~negative regulation of transcription from RNA polymerase II promoter |
6.09E−04 |
FOXL2, OSR2, PTCH1, FOSB, ZEB1, TBL1X, WT1, PEG3 |
GO:0045944~positive regulation of transcription from RNA polymerase II promoter |
7.55E−04 |
FOXL2, OSR2, NDN, IGF1, FOSB, ZEB1, TBL1X, WT1, PEG3 |
GO:0008285~negative regulation of cell proliferation |
1.29E−03 |
ALDH1A2, NDN, SFRP4, ZEB1, PTEN, WT1 |
GO:0007155~cell adhesion |
2.46E−03 |
ISLR, TNXB, COL1A1, CXCL12, COL5A1, SPP1 |
GO:0001568~blood vessel development |
2.83E−03 |
ALDH1A2, COL1A1, COL5A1 |
GO:0001658~branching involved in ureteric bud morphogenesis |
3.45E−03 |
PTCH1, DCHS1, WT1 |
GO:0043434~response to peptide hormone |
3.78E−03 |
COL1A1, SPARC, CXCL12 |
GO:0051591~response to cAMP |
4.12E−03 |
COL1A1, FOSB, SPARC |
GO:0009612~response to mechanical stimulus |
6.70E−03 |
PTCH1, FOSB, CXCL12 |
GO:0030324~lung development |
1.09E−02 |
ALDH1A2, CRISPLD2, SPARC |
GO:0022617~extracellular matrix disassembly |
1.09E−02 |
FBN1, NID1, SPP1 |
GO:0032964~collagen biosynthetic process |
1.24E−02 |
COL1A1, COL5A1 |
GO:0045606~positive regulation of epidermal cell differentiation |
1.45E−02 |
SFRP4, PTCH1 |
GO:0008284~positive regulation of cell proliferation |
1.55E−02 |
ALDH1A2, OSR2, CD248, IGF1, PTEN |
GO:0071711~basement membrane organization |
1.66E−02 |
FLRT2, NID1 |
GO:0032836~glomerular basement membrane development |
1.86E−02 |
NID1, WT1 |
GO:0002576~platelet degranulation |
1.94E−02 |
ISLR, IGF1, SPARC |
GO:0048853~forebrain morphogenesis |
2.07E−02 |
GDF7, PTEN |
GO:0048048~embryonic eye morphogenesis |
2.07E−02 |
FOXL2, FBN1 |
GO:0060322~head development |
2.07E−02 |
EDNRA, OSR2 |
GO:0006366~transcription from RNA polymerase II promoter |
2.13E−02 |
FOXL2, OSR2, NDN, FOSB, WT1 |
GO:0043065~positive regulation of apoptotic process |
2.42E−02 |
ALDH1A2, FOXL2, SFRP4, WT1 |
GO:0042493~response to drug |
2.51E−02 |
PTCH1, COL1A1, FOSB, PTEN |
GO:0007417~central nervous system development |
2.58E−02 |
NDN, ZEB1, PTEN |
GO:0014032~neural crest cell development |
2.68E−02 |
EDNRA, ALDH1A2 |
GO:0001501~skeletal system development |
3.30E−02 |
FBN1, IGF1, COL1A1 |
GO:0048738~cardiac muscle tissue development |
3.49E−02 |
ALDH1A2, PTEN |
GO:0008283~cell proliferation |
4.02E−02 |
EDNRA, IGF1, ZEB1, PTEN |
GO:0017015~regulation of transforming growth factor beta receptor signaling pathway |
4.09E−02 |
LTBP4, ZEB1 |
GO:0007411~axon guidance |
4.32E−02 |
FLRT2, GDF7, CXCL12 |
GO:0016477~cell migration |
4.98E−02 |
CD248, PTEN, COL5A1 |
Cellular component |
GO:0005578~proteinaceous extracellular matrix |
3.29E−08 |
FLRT2, TNXB, TNXA, CRISPLD2, CD248, LTBP4, FBN1, SPARC, COL5A1 |
GO:0005576~extracellular region |
6.52E−07 |
CFB, GDF7, LTBP4, FBN1, IGF1, NID1, SPARC, PTEN, CXCL12, COL5A1, ISLR, CRISPLD2, SFRP4, COL1A1, SPP1 |
GO:0005615~extracellular space |
4.26E−06 |
FLRT2, TNXB, GDF7, CFB, LTBP4, SFRP4, FBN1, IGF1, COL1A1, SPARC, CXCL12, RAMP1, SPP1 |
GO:0031012~extracellular matrix |
2.38E−04 |
TNXB, LTBP4, FBN1, NID1, COL1A1, COL5A1 |
GO:0005604~basement membrane |
4.64E−04 |
FBN1, NID1, SPARC, COL5A1 |
GO:0070062~extracellular exosome |
1.41E−03 |
FLRT2, TNXB, TNXA, CFB, LTBP4, CD248, FBN1, NID1, CXCL12, SLC7A5, COL5A1, ISLR, CRISPLD2, SPP1 |
GO:0031093~platelet alpha granule lumen |
4.99E−03 |
ISLR, IGF1, SPARC |
GO:0042995~cell projection |
9.11E−03 |
NDN, PTEN, SPP1 |
Molecular function |
GO:0005178~integrin binding |
5.03E−05 |
TNXB, LTBP4, FBN1, IGF1, COL5A1 |
GO:0008201~heparin binding |
2.57E−04 |
TNXB, CRISPLD2, FBN1, PTCH1, COL5A1 |
GO:0005201~extracellular matrix structural constituent |
2.99E−04 |
TNXB, FBN1, COL1A1, COL5A1 |
GO:0050840~extracellular matrix binding |
1.17E−03 |
CD248, SPARC, SPP1 |
GO:0005509~calcium ion binding |
2.39E−03 |
SLC24A3, CD248, LTBP4, FBN1, NID1, SPARC, DCHS1 |
GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
1.08E−02 |
FOXL2, NDN, FOSB, WT1 |
GO:0043394~proteoglycan binding |
2.13E−02 |
NID1, COL5A1 |
GO:0048407~platelet-derived growth factor binding |
2.13E−02 |
COL1A1, COL5A1 |
GO:0005159~insulin-like growth factor receptor binding |
2.89E−02 |
SOCS2, IGF1 |
GO:0008083~growth factor activity |
3.98E−02 |
GDF7, IGF1, CXCL12 |